Product Information

ONFI 2.5 MG/ML SUSPENSION is a brand product labeled by Lundbeck Pharmaceuticals LLC, priced at $12.4767 per ML under NDC 67386031321. Its NADAC has been published 657 times since Jan 22, 2014.

FDA first approved this application on Dec 14, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the clobazam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for ONFI 2.5 MG/ML SUSPENSION has been published 657 times since Jan 22, 2014, and over the history we have for it it has risen 190.3%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.